Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia

By Davidson Michael H  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2002-01 ,pp. : 125-141

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

By González Carlos A.   Rubio-Guerra Alberto F.   Pavía Abel   Redding Francisco J.   Cervantes José L.   Zacarías José L.   Yza Rubén   Carranza Jaime   Fernández Pedro   Morales Enrique   Robles Francisco J.   Leyva José L.   Rodríguez Leticia  

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 333-337

Adis International

Access to resources Recommend Favorite

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia

By Filippatos Theodosios D   Elisaf Moses S  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1945-1958

Informa Healthcare

Access to resources Recommend Favorite

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes

By Nelson Robert H   Miles John M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2483-2491

Informa Healthcare

Access to resources Recommend Favorite

Dyslipidaemia treatment guidelines `are outdated'

By  

Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite